Real-time enrollment status for this hepatocellular carcinoma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06040099 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hepatocellular Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 25 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | January 20, 2026 (Jan 20, 2026) |
As of March 2, 2026: Clinical trial NCT06040099 is currently active_not_recruiting participants. This clinical trial study for hepatocellular carcinoma is not currently accepting new participants at 25 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06040099 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06040099 was last updated Jan 20, 2026 (January 20, 2026). HelloStudys verifies this status automatically.